Ovid Therapeutics, Inc. (OVID)
2.40
-0.02
(-0.83%)
USD |
NASDAQ |
Mar 25, 16:00
2.40
0.00 (0.00%)
After-Hours: 07:54
Ovid Therapeutics Enterprise Value : 306.25M for March 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PTC Therapeutics, Inc. | 3.979B |
| CytomX Therapeutics, Inc. | 779.46M |
| Artelo Biosciences, Inc. | 3.648M |
| Eton Pharmaceuticals, Inc. | 655.60M |
| ACADIA Pharmaceuticals, Inc. | 2.985B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 9.664M |
| Revenue (Quarterly) | 0.718M |
| Total Expenses (Quarterly) | -8.946M |
| EPS Diluted (Quarterly) | 0.1183 |
| Gross Profit Margin (Quarterly) | 93.87% |
| Earnings Yield | -10.95% |
| Normalized Earnings Yield | -3.417 |